Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England

Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England

The emergence of the COVID-19 vaccination has been critical in changing the course of the COVID-19 pandemic. To ensure protection remains high in vulnerable groups booster vaccinations in the UK have been targeted based on age and clinical vulnerabilities. We undertook a national retrospective cohor...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Ward, IL, Robertson, C, Agrawal, U, Patterson, L, Bradley, DT, Shi, T, de Lusignan, S, Hobbs, FDR, Sheikh, A, Nafilyan, V
Format:	Journal article
Język:	English
Wydane:	Springer Nature 2024

Podobne zapisy

Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England
od: Isobel L. Ward, i wsp.
Wydane: (2024-01-01)

Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales
od: Bedston, S, i wsp.
Wydane: (2023)

COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
od: Gu, X, i wsp.
Wydane: (2024)

Variation in COVID-19 booster uptake in England: An ecological study.
od: Greg Dropkin
Wydane: (2022-01-01)

Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesResearch in context
od: Stuart Bedston, i wsp.
Wydane: (2024-02-01)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
od: Piotr Rzymski, i wsp.
Wydane: (2021-11-01)

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
od: Agrawal, U, i wsp.
Wydane: (2022)

COVID-19 Vaccine Booster: To Boost or Not to Boost
od: Rahul Shekhar, i wsp.
Wydane: (2021-10-01)

Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru
od: Guido Bendezu-Quispe, i wsp.
Wydane: (2022-07-01)

Excess mortality from COVID-19 in an English sentinel network population
od: Joy, M, i wsp.
Wydane: (2020)

Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine roll-out.
od: Matt Bosworth, i wsp.
Wydane: (2022-08-01)

The Correlates & Public Health Consequences of Prospective Vaccine Hesitancy among Individuals Who Received COVID-19 Vaccine Boosters in the U.S.
od: Matt Motta
Wydane: (2022-10-01)

Waning of first and second dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales
od: Kerr, S, i wsp.
Wydane: (2022)

COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
od: Xinchun Gu, i wsp.
Wydane: (2024-08-01)

Predicting the intention to receive the COVID-19 booster vaccine based on the health belief model
od: Milja Ventonen, i wsp.
Wydane: (2024-06-01)

Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy
od: Lucio Folcarelli, i wsp.
Wydane: (2022-01-01)

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review
od: Yam B. Limbu, i wsp.
Wydane: (2023-03-01)

Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia
od: Li Ping Wong, i wsp.
Wydane: (2022-11-01)

Covid-19 booster shot advisable
od: The Star
Wydane: (2021)

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study
od: Tsang, RSM, i wsp.
Wydane: (2023)

Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England
od: Vahé Nafilyan, i wsp.
Wydane: (2023-03-01)

Longitudinal changes in proportionate mortality due to COVID-19 by occupation in England and Wales
od: Mark Cherrie, i wsp.
Wydane: (2022-11-01)

Factors Influencing the Healthcare Workers’ Willingness to Receive the COVID-19 Booster Dose in Tuscany (Italy)
od: Giovanni Guarducci, i wsp.
Wydane: (2023-11-01)

Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia
od: Kirsten Barnes, i wsp.
Wydane: (2022-10-01)

Bivalent second booster dose of the COVID-19 vaccine: Eligible populations’ reasons for receiving in Italy
od: Giorgia Della Polla, i wsp.
Wydane: (2023-01-01)

Factors Associated With Marshallese and Hispanic Adults’ Willingness to Receive a COVID-19 Booster Dose
od: Rachel S. Purvis, i wsp.
Wydane: (2023-05-01)

Lessons from the English primary care sentinel network's response to the COVID-19 pandemic
od: de Lusignan, S, i wsp.
Wydane: (2023)

Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study
od: Tsang, RS, i wsp.
Wydane: (2023)

Estimating the effectiveness of first dose of COVID-19 vaccine against mortality in England: a quasi-experimental study
od: Bermingham, C, i wsp.
Wydane: (2022)

Evaluation of COVID-19 Booster Vaccine Effectiveness
od: Bingqian Qu, i wsp.
Wydane: (2025-01-01)

Booster Dose of COVID 19 and Ethical Issues
od: Adeela Shahid
Wydane: (2021-12-01)

Booster Vaccination Strategies for “Living With COVID-19”
od: Jung Eun Kim, i wsp.
Wydane: (2022-06-01)

Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England
od: Freja Cordelia Møller Kirsebom, i wsp.
Wydane: (2022-12-01)

Evaluation of the Efficacy of COVID-19 Booster Vaccinations in Healthcare Personnel
od: Chung-Jong Kim, i wsp.
Wydane: (2022-10-01)

Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel
od: Nicholas M. Mohr, i wsp.
Wydane: (2023-12-01)

Healthcare workers’ willingness to receive COVID-19 booster dose and associated factors in the Democratic Republic of the Congo
od: Bertin Mindje Kolomba, i wsp.
Wydane: (2024-12-01)

Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine
od: Piotr Rzymski, i wsp.
Wydane: (2022-05-01)

Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
od: Walid Al-Qerem, i wsp.
Wydane: (2022-03-01)

The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose
od: Liling Chen, i wsp.
Wydane: (2023-01-01)

COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: a national prospective cohort study
od: Bedston, S, i wsp.
Wydane: (2023)